Kamada (KMDA) Net Cash Flow (2012 - 2026)
Kamada's (KMDA) quarterly Net Cash Flow came in at -$42.3 million in Q1 2026, down 1768.71% YoY from $2.5 million in Q1 2025, and down 1272.34% on a QoQ basis from $3.6 million in Q4 2025.
Kamada (KMDA) Net Cash Flow (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Net Cash Flow data on file, last reported at -$42.3 million in Q1 2026.
- Quarterly Net Cash Flow fell 1768.71% year-over-year to -$42.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$42.8 million (down 252.33% YoY) and the FY2025 annual result came in at -$2.7 million, down 111.74% from the prior year.
- Net Cash Flow slipped to -$42.3 million in Q1 2026, from $3.6 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $30.5 million in Q3 2023 to a low of -$42.3 million in Q1 2026.
- A 5-year average of $762796.0 and a median of $2.6 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow jumped 1887639.94% — and 2024, when it sank 108339.56%.
- Tracing KMDA's Net Cash Flow over 5 years: stood at -$3.8 million in 2022, then soared by 166.54% to $2.6 million in 2023, then jumped by 164.71% to $6.8 million in 2024, then tumbled by 46.62% to $3.6 million in 2025, then tumbled by 1272.34% to -$42.3 million in 2026.
- The last three Net Cash Flow figures came in at -$42.3 million (Q1 2026), $3.6 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kamada | 463.48 Mn | 434.00 Mn | 22.47 Mn | -3.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.47 Mn |
| Jun 30, 2026 | -3.47 Mn |
| Mar 31, 2026 | -42.35 Mn |
| Mar 31, 2026 | -42.35 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Sep 30, 2025 | 6.07 Mn |
| Sep 30, 2025 | 6.07 Mn |
| Jun 30, 2025 | -10.11 Mn |
| Jun 30, 2025 | -10.11 Mn |
| Mar 31, 2025 | -2.27 Mn |
| Mar 31, 2025 | -2.27 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Sep 30, 2024 | 15.30 Mn |
| Sep 30, 2024 | 15.30 Mn |
| Jun 30, 2024 | 8.28 Mn |
| Jun 30, 2024 | 8.28 Mn |
| Mar 31, 2024 | -7.40 Mn |
| Mar 31, 2024 | -7.40 Mn |